This is particularly relevant in cancer survivors who face overlapping health risks and systemic vulnerabilities
Gastrointestinal side effects such as nausea, vomiting, and diarrhoeawhich are common with GLP-1 medicationscan contribute to dehydration, electrolyte imbalances, and general malaise
D-carnitina Es una forma inactiva biolgicamente que, adems, puede interferir en la absorcin de otras formas de carnitina
Combined with biomarkers like fasting glucose, insulin resistance, and lipid panels, this personalized context helps providers make evidence-based prescribing decisions
FAQs Are there any serious safety concerns
We sat down with him to discuss the strides GLP-1s have made over the last couple years and where research is headed